Buy & Sell Fidelity National Information Servcs Inc (FIS) – Fidelity National Information Servcs Inc Price Today
Aura AI Summary
Key Stats
- $19.82BMarket Cap
- TechnologySector
- -23.97%3M Drawdown
- $40.21BEnterprise Value
- 4.38%Dividend Yield
- 60% Buy | 40% SellTrading Activity
- 89 daysTypical Hold Time
Fidelity National Information Servcs Inc (FIS) is currently valued at a market capitalization of $19.82B, with an enterprise value of $40.21B. Over the past 52 weeks, Fidelity National Information Servcs Inc has traded between a low of $38.35 and a high of $82.35, highlighting its annual price range. Over the past three months, Fidelity National Information Servcs Inc has recorded a drawdown of -23.97%, reflecting recent price volatility. Fidelity National Information Servcs Inc offers a dividend yield of 4.38%, with the most recent dividend of $0.44 paid on 11 Jun 26. On average, investors hold Fidelity National Information Servcs Inc for approximately 89 days, indicating typical investor behavior on the platform.
About Fidelity National Information Servcs Inc
Fidelity National Information Services' legacy operations provide core and payment processing services to banks, but its business has expanded over time. By acquiring Sungard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS now provides payment processing services for merchants and holds leading positions in the United States and United Kingdom. About a fourth of revenue is generated outside North America.
Most Recent News
Fire engulfs Medline warehouse, causing inventory loss and short-term margin impact.
A fire destroyed Medline's 1 million-square-foot medical equipment warehouse in Tracy, California, affecting about 4% of its U.S. warehouse space. The blaze caused inventory losses and disrupted operations, creating short-term margin pressure as the ...
SpaceX prioritizes growth over profits, following Amazon's strategy to build future value.
SpaceX is choosing to focus on long-term growth rather than immediate profitability, similar to Amazon's approach in its early years. Experts say SpaceX could be profitable now if it reduced spending on projects like Starship and AI infrastructure, b...
New data show Lyell's ronde-cel CAR T-cell therapy is safe and effective for large B-cell lymphoma.
Lyell Immunopharma presented updated safety and translational data for its CAR T-cell therapy, ronde-cel, in treating relapsed or refractory large B-cell lymphoma (LBCL). Over 100 patients treated showed no severe cytokine release syndrome (CRS) and ...